Abstract
Recent reports have shown that angiogenesis favors tumor growth and facilitates entry of cells into the circulation (8, 9) . VCAM-1 binds with high affinity to the integrin α4β1 (also known as very-late antigen, VLA-4) and α4β7.
Material and Method

Patients
Sixty specimens of colorectal cancer tissues were 
Results
VCAM-1 Expression and Its Relation to Clinicopathologic Parameters
Colonic cancer tissue was obtained from 31 female and 29 male patients undergoing surgery for sporadic colon cancer. The Characteristic of patients are listed in Table 1 .
The average age of the patients was 50. Patients with average age older than 50 years were 61% (n=37) and average age of patients of younger than 50 years were 38% (n=23). There was no significant correlation between VCAM-1 expression level with age (P=0.103).
According to stages of the colorectal cancer that were histologically diagnosed, study of VCAM-1 expression in stage0 (n=3)5%, stage1 (n=17)28%, stage2 (n=16) 26%, stage 3(n=17)28% and stage4 (n=7)12% of the patients was performed. In the present study data analysis showed that VCAM-1 expression level was correlated with stage of colorectal cancer (P=<0.000*).
In this study, there was no relation between VCAM-1 expression in colorectal cancer patients and tumor metastasis (than patients with primary tumors and nonmetastatic colorectal cancer) (P=0.276).
The patients were divided into two groups according to tumor progression. The first group was based on the TNM classification. In This Category, VCAM-1 expression with tumor progression in the colon of walls was considerably significant (P=0.000*). Frequency classification of tumor progression included Tx (n=4, 7%), T2 (n=14, 23%), T3 (n=34, 57%) and T4 (n=8, 13%) in these patients, respectively. The second group was based on T1-T2 (n=20, 33%) and T3-T4 (n=40, 67%). The second group also had a significant association between expression VCAM-1 and tumor progression (P=0.003*).
Relationship between VCAM-1 expression and clinical risk factors of tumor size was measured in three groups.
Most of the patients had tumor size between 1.5-3 cm The controversial results which are obtained from several studies, show that serum levels of a variety of adhesion molecules, including VCAM-1 in cancer samples compared to normal samples has increased in various cancers (7, 15, 26, 27 ).
In conclusion, we report that expression of VCAM-1 is associated with lymph node involvement, lymph node metastasis, clinical stage, tumor progression in the colon wall layers and gender of patients in colorectal cancer.
The correlation with clinicopathologic factors including tumor progression, and involvement and metastasis of lymph node, the crucial role of VCAM-1 in cancer cell adhesion and spreading, and blood vessel development and angiogenesis determines. Since only patients with zero or only one metastatic site were enrolled in this study, further investigation on patients with higher degree metastasis is recommended.
